Article
A Population-Based Study of Genes Previously Implicated in Breast Cancer.
The New England journal of medicine - 4 Feb 2021
Hu Chunling, Hart Steven N, Gnanaolivu Rohan, Huang Hongyan, Lee Kun Y, Na Jie, Gao Chi, Lilyquist Jenna, Yadav Siddhartha, Boddicker Nicholas J, Samara Raed, Klebba Josh, Ambrosone Christine B, Anton-Culver Hoda, Auer Paul, Bandera Elisa V, Bernstein Leslie, Bertrand Kimberly A, Burnside Elizabeth S, Carter Brian D, Eliassen Heather, Gapstur Susan M, Gaudet Mia, Haiman Christopher, Hodge James M, Hunter David J, Jacobs Eric J, John Esther M, Kooperberg Charles, Kurian Allison W, Le Marchand Loic, Lindstroem Sara, Lindstrom Tricia, Ma Huiyan, Neuhausen Susan, Newcomb Polly A, O'Brien Katie M, Olson Janet E, Ong Irene M, Pal Tuya, Palmer Julie R, Patel Alpa V, Reid Sonya, Rosenberg Lynn, Sandler Dale P, Scott Christopher, Tamimi Rulla, Taylor Jack A, Trentham-Dietz Amy, Vachon Celine M, Weinberg Clarice, Yao Song, Ziogas Argyrios, Weitzel Jeffrey N, Goldgar David E, Domchek Susan M, Nathanson Katherine L, Kraft Peter, Polley Eric C, Couch Fergus J
Abstract excerpt
BACKGROUND: Population-based estimates of the risk of breast cancer associated with germline pathogenic variants in cancer-predisposition genes are critically needed for risk assessment and management in women with inherited pathogenic variants. METHODS: In a population-based case-control study, we performed sequencing using a custom multigene amplicon-based panel to identify germline pathogenic variants in 28...
Read the complete abstract on PubMed